StonvexLoading…
StonvexStonvexStonvexCore line items from MBRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-25.10M | $-26.64M | $-29.63M | $-30.64M |
Net Income | $-33.56M | $-26.05M | $-29.77M | $-29.02M |
EPS (Diluted) | $-28.42 | $-189.14 | $-15.07 | $-15.22 |
Total Assets | $22.13M | $16.93M | $38.22M | $57.42M |
Total Liabilities | $7.12M | $5.72M | $12.14M | $5.23M |
Cash & Equivalents | $8.88M | $4.28M | $23.55M | $43.15M |
Free Cash Flow OCF − CapEx | $-22.73M | $-23.88M | $-23.71M | $-27.71M |
Shares Outstanding | 3.20M | 135.16K | 2.23M | 1.91M |